Pharmaceutical Advertising Injunction Upheld
Legislator-Zusammenfassung
KI-generiertThe court affirmed the partial granting of preliminary injunctions against a competitor regarding advertising claims for a drug treating renal anemia, holding that for such measures under unfair competition law, an unlawful act and an irreparable disadvantage must be made plausible. The court reasoned that advertising for pharmaceuticals, even in professional media, must comply with unfair competition and drug laws, and that the defendants' claims of industry-wide accepted advertising practices were an inadmissible "unclean hands" defense. Furthermore, the alleged disadvantage to the applicant, stemming from threatened market confusion and dilution, as well as reputational harm, qualified as not easily reparable, justifying the injunction pending the main proceedings.
Legislator-Regeste
AmtlichArt. 2 f. UWG; Art. 31 f. HMG; Art. 28c - 28f ZGB. Voraussetzungen für den Erlass vorsorglicher Massnahmen im UWG. Auch in der Fachwerbung haben die Werbeaussagen vor dem UWG und dem Heilmittelrecht standzuhalten. Der nicht leicht wieder gutzumachende Nachteil kann in der drohenden Marktverwirrung und Marktverwässerung bestehen. | UWG (unlauterer Wettbewerb)
Schlagwörter
KI-generiertZitierte Gesetzesbestimmungen
KI-generiertZitierte Rechtsprechung
KI-generiertVerwandte Entscheide
KI-generiertZentrale Rechtsfragen, extrahiert von Legislator
KI-generiertCited as the basis for the application of provisional measures rules from the Swiss Civil Code (ZGB) concerning personality protection.
Cited as the requirement for unlawful conduct, which must be present for provisional measures to be ordered.
Cited as the source for the regulation of provisional measures in unfair competition law.
Cited as an example of conduct considered unfair competition.
Cited in relation to the unlawfulness of comparative advertising statements.
Cited in relation to the unlawfulness of advertising statements in the context of drug advertising law.
Cited in relation to the requirement that drug advertising statements must not be misleading.
Cited in relation to the requirement that comparative statements about medicines must be scientifically correct.
Cited regarding the prohibition on using the word 'sicher' (safe) in specialist advertising unless qualified.
Cited in the introductory/summary paragraph regarding the context of the case (drug advertising).
Volltext
Rechtsprechung Luzern
Instanz: · Obergericht
Abteilung: · I. Kammer
Rechtsgebiet: · UWG (unlauterer Wettbewerb)
Entscheiddatum: · 15.07.2004
Fallnummer: · 11 04 85.1
LGVE: · 2004 I Nr. 29
Leitsatz: · Art. 2 f. UWG; Art. 31 f. HMG; Art. 28c - 28f ZGB. Voraussetzungen für den Erlass vorsorglicher Massnahmen im UWG. Auch in der Fachwerbung haben die Werbeaussagen vor dem UWG und dem Heilmittelrecht standzuhalten. Der nicht leicht wieder gutzumachende Nachteil kann in der drohenden Marktverwirrung und Marktverwässerung bestehen.
Rechtskraft: · Diese Entscheidung ist rechtskräftig.